🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The study will be conducted in compliance with the International Council fo...
Status
Completed
Location
Local Institution - 338
Start Date
2019-05-20
Trial ID
NCT03900715
Treatments Being Tested
Human immunoglobulin (Ig) is the most commonly used blood product. It has b...
Status
Completed
Location
Chungnam National University Hospital
Start Date
2014-06
Trial ID
NCT02063789
Treatments Being Tested
The study is a factorial randomized controlled trial investigating the effi...
Status
Completed
Location
Linköping University
Start Date
2020-01-13
Trial ID
NCT04260750
Treatments Being Tested
At present, the families of cancer patients are lack knowledge and experien...
Status
Completed
Location
Taipei Medical University
Start Date
2021-06-25
Trial ID
NCT05030090
The purpose of this study is to determine the recommended Phase 2 dose(s) (...
Status
Recruiting
Location
City of Hope
Start Date
2021-05-19
Trial ID
NCT04811560
Treatments Being Tested
This study includes two parts:Part 1: SSGJ-707 (different dosing regimens) ...
Status
Recruiting
Location
Liu Tianshu
Start Date
2024-09-03
Trial ID
NCT06493760
Treatments Being Tested
Coronary artery disease (CAD) is a major chronic condition severely impacti...
Status
Enrolling By Invitation
Location
The First Affiliated Hospital of Bengbu Medical University
Start Date
2024-10-20
Trial ID
NCT07330882
This is a phase I/II, open-label, dose-escalation study designed to evaluat...
Status
Active Not Recruiting
Location
City of Hope Medical Center
Start Date
2019-08-13
Trial ID
NCT04077723
Treatments Being Tested
The overall aim of the project is to gain knowledge about the expected cour...
Status
Unknown
Location
Oslo University Hospital
Start Date
2023-06-01
Trial ID
NCT05898347
Treatments Being Tested
ZL-82 tablets are highly selective covalent irreversible inhibitors of non-...
Status
Completed
Location
Peking University Medical Shandong Hospital of Traditional Chinese Medicine
Start Date
2024-03-19
Trial ID
NCT06432738
Treatments Being Tested